Solid Tumor

Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease

Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor.

Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS

Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma

Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation

Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma

Study of Sacituzumab Govitecan in Patients With Solid Tumor

Study of Magrolimab in Patients With Solid Tumors

PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid Tumors

Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)

BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors

A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients

BGJ398 for Patients With Tumors With FGFR Genetic Alterations

LGX818 for Patients With BRAFV600 Mutated Tumors

Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Phase 2 Study of SAR302503 in Patients With Myelofibrosis

A Study in Advanced Solid Tumors

A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram

Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors

IN10018 Combination Therapy in Previously-treated Solid Tumors

A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Therapies in the Treatment of Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation

First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer

A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically

ALG.APV-527 First-in-human Study

a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors

Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors

Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1

HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors

A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors

A Study of NDI 1150-101 in Patients With Solid Tumors

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors

Study of ADG106 In Combination With PD-1 Antibody In Advanced or Metastatic Solid Tumors and/or Non Hodgkin Lymphoma

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143

Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors

Clinical Study of ICP-192 in Solid Tumors Patients